Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Comparative, Double-blind, Parallel-group Study to Evaluate the Digestive Tolerability of ART44 Versus ART®50 in Patients With Osteoarthritis of the Knee

NCT01009671 is registered in ClinicalTrials.gov with Laboratoires NEGMA as lead sponsor.

NCT NCT01009671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01009671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Comparative, Double-blind, Parallel-group Study to Evaluate the Digestive Tolerability of ART44 Versus ART®50 in Patients With Osteoarthritis of the Knee
Lead sponsor
Laboratoires NEGMA
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2009
Completion date
October 31, 2010
Enrollment
210 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis